Literature DB >> 15083369

Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training.

Martine A I Thomis1, Wim Huygens, Sofie Heuninckx, Monique Chagnon, Hermine H M Maes, Albrecht L Claessens, Robert Vlietinck, Claude Bouchard, Gaston P Beunen.   

Abstract

This study explores the associations between polymorphisms in two candidate genes-myostatin gene (MSTN or GDF8) and angiotensin-converting enzyme (ACE) gene-with interindividual differences in human muscle mass and strength responses to strength training. The MSTN AluI A55T (exon 1), BanII K153R, TaqI E164 K and BstNI P198A (all in exon 2) markers and the ACE insertion (I)/deletion (D) polymorphism were typed in 57 males [22.4 (3.7) years] who participated in a 10-week, high-resistance training program for the elbow flexors. Maximal strength, and maximal isometric and concentric elbow flexor torques were measured at baseline and after training. Information on muscle cross-sectional area of the upper arm was obtained by computer tomography scans. Only one individual was heterozygous for the MSTN BanII K153R variant. No allelic variant was detected at the other MSTN sites in this population. For the ACE I/D polymorphism, no evidence was found for an association of the D or I allele with baseline strength, isometric and concentric torque or arm muscle cross-sectional area [analysis of covariance (ANCOVA) 0.25< P<0.97]. Responses to the strength-training program were not associated with the ACE I/D genotype (ANCOVA 0.057< P<0.70). Borderline significance was found for larger strength gains in dynamic flexion torques for I/I genotypes. This study therefore does not support the hypothesis that an increased muscle fiber hypertrophic effect of strength training is present in D-allele carriers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083369     DOI: 10.1007/s00421-004-1093-6

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  38 in total

1.  RAS genes influence exercise-induced left ventricular hypertrophy: an elite athletes study.

Authors:  C Fatini; R Guazzelli; P Manetti; B Battaglini; F Gensini; R Vono; L Toncelli; P Zilli; A Capalbo; R Abbate; G F Gensini; G Galanti
Journal:  Med Sci Sports Exerc       Date:  2000-11       Impact factor: 5.411

2.  Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle.

Authors:  R Kambadur; M Sharma; T P Smith; J J Bass
Journal:  Genome Res       Date:  1997-09       Impact factor: 9.043

3.  Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle.

Authors:  L Grobet; D Poncelet; L J Royo; B Brouwers; D Pirottin; C Michaux; F Ménissier; M Zanotti; S Dunner; M Georges
Journal:  Mamm Genome       Date:  1998-03       Impact factor: 2.957

4.  Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting.

Authors:  K E Yarasheski; S Bhasin; I Sinha-Hikim; J Pak-Loduca; N F Gonzalez-Cadavid
Journal:  J Nutr Health Aging       Date:  2002       Impact factor: 4.075

5.  Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort.

Authors:  M J Seibert; Q L Xue; L P Fried; J D Walston
Journal:  J Am Geriatr Soc       Date:  2001-08       Impact factor: 5.562

Review 6.  The human gene map for performance and health-related fitness phenotypes: the 2001 update.

Authors:  Tuomo Rankinen; Louis Pérusse; Rainer Rauramaa; Miguel A Rivera; Bernd Wolfarth; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2002-08       Impact factor: 5.411

7.  Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens.

Authors:  R Reneland; H Lithell
Journal:  Scand J Clin Lab Invest       Date:  1994-04       Impact factor: 1.713

8.  Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication.

Authors:  Stephen M Roth; Gregory F Martel; Robert E Ferrell; E Jeffrey Metter; Ben F Hurley; Marc A Rogers
Journal:  Exp Biol Med (Maywood)       Date:  2003-06

9.  Angiotensin II-mediated facilitation of sympathetic neurotransmission in the spontaneously hypertensive rat is not associated with neuronal uptake of the peptide.

Authors:  J R Jonsson; S D Smid; D B Frewin; R J Head
Journal:  J Cardiovasc Pharmacol       Date:  1993-11       Impact factor: 3.105

Review 10.  Human performance: a role for the ACE genotype?

Authors:  Alun Jones; Hugh E Montgomery; David R Woods
Journal:  Exerc Sport Sci Rev       Date:  2002-10       Impact factor: 6.230

View more
  23 in total

Review 1.  Association of genetic factors with selected measures of physical performance.

Authors:  William R Thompson; Stuart A Binder-Macleod
Journal:  Phys Ther       Date:  2006-04

Review 2.  New fundamental resistance exercise determinants of molecular and cellular muscle adaptations.

Authors:  Marco Toigo; Urs Boutellier
Journal:  Eur J Appl Physiol       Date:  2006-08       Impact factor: 3.078

3.  Association between ACE D allele and elite short distance swimming.

Authors:  Aldo Matos Costa; António José Silva; Nuno Domingos Garrido; Hugo Louro; Ricardo Jacó de Oliveira; Luiza Breitenfeld
Journal:  Eur J Appl Physiol       Date:  2009-05-21       Impact factor: 3.078

4.  Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes.

Authors:  Aldo Matos Costa; António José Silva; Nuno Garrido; Hugo Louro; Daniel Almeida Marinho; Mário Cardoso Marques; Luiza Breitenfeld
Journal:  J Sports Sci Med       Date:  2009-09-01       Impact factor: 2.988

Review 5.  The ACE gene and human performance: 12 years on.

Authors:  Zudin Puthucheary; James R A Skipworth; Jai Rawal; Mike Loosemore; Ken Van Someren; Hugh E Montgomery
Journal:  Sports Med       Date:  2011-06-01       Impact factor: 11.136

Review 6.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

Review 7.  Molecular genetic studies of gene identification for sarcopenia.

Authors:  Li-Jun Tan; Shan-Lin Liu; Shu-Feng Lei; Christopher J Papasian; Hong-Wen Deng
Journal:  Hum Genet       Date:  2011-06-26       Impact factor: 4.132

8.  Human adaptive evolution at Myostatin (GDF8), a regulator of muscle growth.

Authors:  Matthew A Saunders; Jeffrey M Good; Elizabeth C Lawrence; Robert E Ferrell; Wen-Hsiung Li; Michael W Nachman
Journal:  Am J Hum Genet       Date:  2006-10-10       Impact factor: 11.025

9.  Association of circulating angiotensin converting enzyme activity with respiratory muscle function in infants.

Authors:  Gabriel Dimitriou; Despina Papakonstantinou; Eleana F Stavrou; Sotirios Tzifas; Aggeliki Vervenioti; Anny Onufriou; Aglaia Athanassiadou; Stefanos Mantagos
Journal:  Respir Res       Date:  2010-05-12

10.  Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity.

Authors:  Matthew A Kostek; Theodore J Angelopoulos; Priscilla M Clarkson; Paul M Gordon; Niall M Moyna; Paul S Visich; Robert F Zoeller; Thomas B Price; Richard L Seip; Paul D Thompson; Joseph M Devaney; Heather Gordish-Dressman; Eric P Hoffman; Linda S Pescatello
Journal:  Med Sci Sports Exerc       Date:  2009-05       Impact factor: 5.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.